Cancer arises from genetic alterations that invariably lead to dysregulated transcriptional
programs. These dysregulated programs can cause cancer cells to become highly
dependent on certain regulators of gene expression. Here, we discuss how transcriptional
control is disrupted by genetic alterations in cancer cells, why transcriptional dependencies
can develop as a consequence of dysregulated programs, and how these dependencies
provide opportunities for novel therapeutic interventions in cancer.